# OnCo record asp2998 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/asp2998/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "asp2998" ;
  schema:name "ASP2998"@en ;
  schema:description "An experimental drug that uses an antibody to deliver a cancer-killing drug and an immune activator to cells carrying TROP2. An early human study is recruiting; benefit and safety are still being tested."@en ;
  schema:url <https://onco.cc/drugs/asp2998/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://www.astellas.com/en/science/research-and-development/pipeline>, <https://www.astellas.com/content/dam/astellas-com/global/en/confidential-documents/financial-results/4q2025_sup_en.pdf>, <https://www.astellas.com/content/dam/astellas-com/global/en/confidential-documents/financial-results/4q2025_pre_en.pdf>, <https://doi.org/10.1200/jco.2026.44.16_suppl.tps2665>, <https://clinicaltrials.gov/study/NCT07287995> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "dual-payload", "immunostimulatory" ;
  onco:modality "ADC" ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/dual-payload-adc/> ;
  onco:targets <https://onco.cc/targets/trop2/> ;
  onco:companies <https://onco.cc/companies/astellas/> ;
  onco:trials <https://onco.cc/trials/nct07287995/> .